Philip J. Vickers

Insider Reports History

Entity
Individual
Location
C/O Revance Therapeutics, Inc., 7555 Gateway Boulevard, Newark, CA
Signature
/s/ Steven Avruch, Attorney-in-Fact for Philip J. Vickers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip J. Vickers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVROBIO, Inc. Director Stock Option (Right to Buy) 17.6K Jun 6, 2023 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 10.8K May 4, 2022 Direct

Insider Reports Filed by Philip J. Vickers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVRO AVROBIO, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
AVRO AVROBIO, Inc. Jun 8, 2022 2 $0 4 Jun 10, 2022 Director
RVNC Revance Therapeutics, Inc. May 4, 2022 1 $0 4/A May 13, 2022 Director
AVRO AVROBIO, Inc. Jul 7, 2021 1 $40.1K 4 Jul 8, 2021 Director
AVRO AVROBIO, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
RVNC Revance Therapeutics, Inc. May 5, 2021 2 $0 4 May 7, 2021 Director